Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

NCT02624492

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Jessa Ziekenhuis - Campus Virga Jesse Hasselt, Belgium
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
  • Istituto Clinico Humanitas Rozzano (MI), Italy
  • A. O. S. Maria della Misericordia Udine, Italy
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)

NCT02187861

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • UCLA School of Medicine; Hematology/Oncology Los Angeles, California, United States
  • Nothwest Georgia Oncology Centers P.C Austell, Georgia, United States
View all 71 locations
View Trial Details
Completed

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

NCT00987493

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • St. Claraspital AG Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View all 16 locations
View Trial Details
Completed

Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

NCT00227695

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Clinical Center - Institute of Hematology São Paulo, Brazil
  • Istituto Europeo di Oncologia IEO Milan, Italy
  • Clinical Center Skopje Skopje, North Macedonia
  • Clinical Center of Serbia Belgrade, Serbia
View all 26 locations
View Trial Details

Related conditions